Refactor Capital logo

Refactor Capital

www.refactor.com

VCMatch tracks Refactor Capital as an investor focused on Space Tech, Biotech, and Climate/Cleantech companies, Pre-Seed and Seed rounds, United States markets, and $1m to $2m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$1m to $2m

Stages

Pre-Seed, Seed

Geography

United States

Investment Thesis

Refactor invests in seed-stage hard tech founders who aim to commercialize real science and scale real systems. The firm believes that ‘the most enduring companies are created by founders willing to commercialize real science and scale real systems.’ They focus on companies solving ‘hard but not impossible problems’ at the intersection of computation and physical sciences, with the goal of refactoring—improving efficiency and scalability—within their respective industries.

Is Refactor Capital right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

Investment Focus

Who should take a closer look

Refactor Capital is most relevant for founders raising Pre-Seed and Seed rounds in Space Tech, Biotech, Climate/Cleantech, and Energy, especially across United States, with public check-size signals around $1m to $2m.

Focus statement

Refactor invests in seed-stage hard tech companies primarily in the US, typically leading or co-leading pre-seed and seed rounds with $1-2M checks. They target 10% ownership and focus on domains including aerospace, biotech, critical materials, earth systems, energy, and health.

Value Add

  • Solo capitalist structure - Zal Bilimoria is the only employee, enabling fast decision-making and direct founder access
  • Personal, hands-on approach: 'I will make your vision and journey my primary focus. Expect highly responsive, one-on-one attention from me'
  • Deep technical expertise from Zal's background at a16z leading early bio and health investments and helping launch a16z's first Bio Fund
  • Comprehensive founder support beyond capital including CFO support, communications training, and mental fitness programs
  • Consistent track record across fund cycles - 4 funds with $225M in AUM, expanding into new hard tech domains nearly every year

Stage And Sector Fit

Portfolio Highlights

General Galactic

Aerospace

Astranis

Aerospace

Octant

Biotech

Miist

Biotech

Parallel Bio

Biotech

BBB

Biotech

Biorender

Biotech

Epana

Biotech

+ 51 more companies in their portfolio